Significantly, pre-treatment with the anti-STn ADC S3F-CL-MMAE in an extreme limiting dilution assay dramatically reduced the sphere formation capacity of OVCAR3 and OV90 cells suggesting direct targeting of STn+ cells impacts cancer stem cell frequency. The gene discussed is EEF1A2; the disease is cancer.